Literature DB >> 16332249

A positively charged cluster in the epidermal growth factor-like domain of Factor VII-activating protease (FSAP) is essential for polyanion binding.

Boran Altincicek1, Aya Shibamiya, Heidi Trusheim, Eleni Tzima, Michael Niepmann, Dietmar Linder, Klaus T Preissner, Sandip M Kanse.   

Abstract

FSAP (Factor VII-activating protease) is a novel plasma-derived serine protease that regulates haemostasis as well as vascular cell proliferation. FSAP undergoes autoactivation in the presence of polyanionic macromolecules such as heparin and RNA. Competition experiments suggest that RNA and heparin bind to the same or overlapping interaction sites. A proteolysis approach, where FSAP was hydrolysed into smaller fragments, was used to identify the polyanion-binding site. The EGF (epidermal growth factor)-like domains EGF2 and EGF3 of FSAP are the major interaction domains for RNA. The amino acids Arg170, Arg171, Ser172 and Lys173 within the EGF3 domain were essential for this binding. This is also the region with the highest positive net charge in the protein and is most probably located in an exposed loop. It is also highly conserved across five species. Disruption of disulphide bridges led to the loss of RNA and heparin binding, indicating that the three-dimensional structure of the EGF3 domain is essential for binding to negatively charged heparin or RNA. The identification of polyanion-binding sites will help to define the role of FSAP in the vasculature.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16332249      PMCID: PMC1383718          DOI: 10.1042/BJ20051563

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Structure/function analysis of human factor XII using recombinant deletion mutants. Evidence for an additional region involved in the binding to negatively charged surfaces.

Authors:  F Citarella; D M Ravon; B Pascucci; A Felici; A Fantoni; C E Hack
Journal:  Eur J Biochem       Date:  1996-05-15

2.  Measurement of the binding of antifibrinolytic amino acids to various plasminogens.

Authors:  W J Brockway; F J Castellino
Journal:  Arch Biochem Biophys       Date:  1972-07       Impact factor: 4.013

3.  Structural variety of arginine-rich RNA-binding peptides.

Authors:  R Tan; A D Frankel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

4.  RNA-binding patterns in total human tissue proteins: analysis by northwestern blotting.

Authors:  X Chen; J Sadlock; E A Schon
Journal:  Biochem Biophys Res Commun       Date:  1993-02-26       Impact factor: 3.575

5.  Factor XII: Hageman factor.

Authors:  R A Pixley; R W Colman
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

6.  Factor VII-activating protease (FSAP) inhibits growth factor-mediated cell proliferation and migration of vascular smooth muscle cells.

Authors:  Christian Kannemeier; Nadia Al-Fakhri; Klaus T Preissner; Sandip M Kanse
Journal:  FASEB J       Date:  2004-02-20       Impact factor: 5.191

7.  Purification and characterization of a novel hyaluronan-binding protein (PHBP) from human plasma: it has three EGF, a kringle and a serine protease domain, similar to hepatocyte growth factor activator.

Authors:  N H Choi-Miura; T Tobe; J Sumiya; Y Nakano; Y Sano; T Mazda; M Tomita
Journal:  J Biochem       Date:  1996-06       Impact factor: 3.387

8.  The solution structure and backbone dynamics of the fibronectin type I and epidermal growth factor-like pair of modules of tissue-type plasminogen activator.

Authors:  B O Smith; A K Downing; P C Driscoll; T J Dudgeon; I D Campbell
Journal:  Structure       Date:  1995-08-15       Impact factor: 5.006

9.  Inhibition of bFGF/EGF-dependent endothelial cell proliferation by the hyaluronan-binding protease from human plasma.

Authors:  Michael Etscheid; Nicole Beer; Julia Anne Kress; Rainer Seitz; Johannes Dodt
Journal:  Eur J Cell Biol       Date:  2004-01       Impact factor: 4.492

10.  In vitro activation of the contact (Hageman factor) system of plasma by heparin and chondroitin sulfate E.

Authors:  Y Hojima; C G Cochrane; R C Wiggins; K F Austen; R L Stevens
Journal:  Blood       Date:  1984-06       Impact factor: 22.113

View more
  10 in total

Review 1.  Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology.

Authors:  Frances E Lennon; Patrick A Singleton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-05-13       Impact factor: 5.464

2.  Factor VII-activating protease promotes the proteolysis and inhibition of tissue factor pathway inhibitor.

Authors:  Sandip M Kanse; Paul J Declerck; Wolfram Ruf; George Broze; Michael Etscheid
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11-23       Impact factor: 8.311

3.  Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation.

Authors:  Christian Kannemeier; Aya Shibamiya; Fumie Nakazawa; Heidi Trusheim; Clemens Ruppert; Philipp Markart; Yutong Song; Eleni Tzima; Elisabeth Kennerknecht; Michael Niepmann; Marie-Luise von Bruehl; Daniel Sedding; Steffen Massberg; Andreas Günther; Bernd Engelmann; Klaus T Preissner
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-03       Impact factor: 11.205

4.  Nucleic acids potentiate Factor VII-activating protease (FSAP)-mediated cleavage of platelet-derived growth factor-BB and inhibition of vascular smooth muscle cell proliferation.

Authors:  Aya Shibamiya; Lars Muhl; Susanne Tannert-Otto; Klaus T Preissner; Sandip M Kanse
Journal:  Biochem J       Date:  2007-05-15       Impact factor: 3.857

5.  Inhibition of PDGF-BB by Factor VII-activating protease (FSAP) is neutralized by protease nexin-1, and the FSAP-inhibitor complexes are internalized via LRP.

Authors:  Lars Muhl; Anders Nykjaer; Malgorzata Wygrecka; Denis Monard; Klaus T Preissner; Sandip M Kanse
Journal:  Biochem J       Date:  2007-06-01       Impact factor: 3.857

6.  Microbial metalloproteinases mediate sensing of invading pathogens and activate innate immune responses in the lepidopteran model host Galleria mellonella.

Authors:  Boran Altincicek; Monica Linder; Dietmar Linder; Klaus T Preissner; Andreas Vilcinskas
Journal:  Infect Immun       Date:  2006-10-30       Impact factor: 3.441

7.  Hyaluronic Acid binding protein 2 is a novel regulator of vascular integrity.

Authors:  Nurbek Mambetsariev; Tamara Mirzapoiazova; Bolot Mambetsariev; Saad Sammani; Frances E Lennon; Joe G N Garcia; Patrick A Singleton
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-12-30       Impact factor: 8.311

8.  Identification of a Phage Display-Derived Peptide Interacting with the N-Terminal Region of Factor VII Activating Protease (FSAP) Enables Characterization of Zymogen Activation.

Authors:  Sebastian Berge-Seidl; Nis Valentin Nielsen; Armando A Rodriguez Alfonso; Michael Etscheid; Sai Priya Sarma Kandanur; Bengt Erik Haug; Maria Stensland; Bernd Thiede; Merve Karacan; Nico Preising; Sebastian Wiese; Ludger Ständker; Paul J Declerck; Geir Åge Løset; Sandip M Kanse
Journal:  ACS Chem Biol       Date:  2022-09-07       Impact factor: 4.634

9.  HABP2 is a Novel Regulator of Hyaluronan-Mediated Human Lung Cancer Progression.

Authors:  Tamara Mirzapoiazova; Nurbek Mambetsariev; Frances E Lennon; Bolot Mambetsariev; Joshua E Berlind; Ravi Salgia; Patrick A Singleton
Journal:  Front Oncol       Date:  2015-07-21       Impact factor: 6.244

10.  Plasminogen activator inhibitor-1 is an inhibitor of factor VII-activating protease in patients with acute respiratory distress syndrome.

Authors:  Malgorzata Wygrecka; Rory E Morty; Philipp Markart; Sandip M Kanse; Peter A Andreasen; Troels Wind; Andreas Guenther; Klaus T Preissner
Journal:  J Biol Chem       Date:  2007-05-31       Impact factor: 5.157

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.